The Newswire for Business Lawyers

Sun Pharma Fires Back At Biovail In Cardizem Suit

Law360, New York (November 19, 2008) -- Indian generics maker Sun Pharmaceutical Industries Ltd. has accused Biovail Laboratories International SRL of violating antitrust laws and misleading the U.S. Patent and Trademark Office in a new set of counterclaims regarding patents for the hypertension drug Cardizem.

Sun lodged a slew of counterclaims in the U.S. District Court for the District of New Jersey on Tuesday in an attempt to invalidate three of Biovail's patents for various...

Login

E-mail
Password
 
  I forgot my login details.

For the whole story, take a 7-day free trial.
  Register to try Law360 for free for seven days:
*
*
*
*
*
*Required
Select at least
one practice area:*

Bankruptcy
Competition
Employment
Energy
Environmental
Financial Services
Health
Intellectual Property
Insurance
Product Liability
Real Estate
Securities
Technology

You will be added to
the e-mail newsletter distribution.

You will be sent an e-mail to confirm your e-mail address.
The only daily news service covering every major practice area of the law.
  • Breaking news available nowhere else
  • More than 66% of articles published before or simultaneously with any other source
  • 44% of articles have critical legal documents attached
  • More than 1,000 columns by leading practitioners published per year
  • More than 14,000 exclusive articles published per year
  • Detailed coverage of 13 major practice areas